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1. Introduction
  The twin infections of malaria and hepatitis B remain 
serious health issues in developing countries. Malaria fever 
is a life threatening infection, especially in Sub-Saharan 
Africa with approximately 350-500 million cases yearly, 
with 2-3 million annual deaths[1]. Malaria fever is caused 
by Plasmodia, transmitted through the bite of an infected 
female anopheles mosquito.
  Hepatitis B infection (HBI) is caused by hepatitis B virus 
(HBV). HBI is as a result of exposure to blood or other body 
fluids containing HBV[2]. An estimated 350 million persons 
worldwide are chronic carriers[3,4], though adequate and 
accurate data is lacking on actual rates of infection[5]. 
4 million clinical cases of HBI infection are recorded 
each year, with about 1 million deaths as a result of 
complications, including liver cancers[6,7].
2. Materials and methods
2.1. Ethical issues
  Ethical clearance was obtained from the ethical 
committee of the center before the collection of samples 
commenced. No contact was made between the patients 
and the researchers. Samples used for the study were those 
collected from potential blood donors by designated hospital 
staff for laboratory analysis.
2.2. Study area
  The study was carried out within a six month period; July 
to December, 2009, at a Tertiary Health Institution, the 
Bishop Murray Medical Centre in Makurdi, Benue State, 
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Nigeria. Makurdi, the Benue state capital, according to 
Kogbe et al[8] is located on longitude 80曘31’ E and latitude 
70曘45’ N. It is 90 metres above sea level. It has a tropical 
climate with distinct rainy and dry seasons; the wet season 
which runs from April to October, has well distributed 
rainfall with a monthly mean of 155.53 mm, an annual 
mean of 1 244.30 mm, and a peak in July/August and the 
dry season which runs from November to March with very 
little rainfall. Mean monthly relative humidity at 12.00 GMT 
range from 66%-68% in the rainy season and 15%-40% in 
the dry season, with an annual mean value of 60%. Mean daily 
temperature varies from 15.6 曟 in December/January to 38 曟 
in February/March with an annual mean value of 27.5 曟[9].
  Thin and thick films were used for the examination of 
blood for Plasmodia[10-16]. Thick films were used for the 
determination of parasite densities and thin films for their 
identification[17]. One step HB surface antigen test strips 
were used for the diagnosis of HBV infection[10]. All tests 
were carried out according to standard procedures and 
practices[7,10].
3. Results
  Table 1 shows that three hundred and thirty-seven (337) 
samples were examined; highest rates of infection with both 
Plasmodia (mp) and HBV (HBsAg) occurred in the month of 
December at 59(17.51%), while least infection occurred in 
September at 40(11.9%) respectively. Males had higher rates 
of infection compared to females with Plasmodia and HBV at 
129(38.3%) to 8(2.37%) respectively. Males were more likely 
to be infected than females (P<0.05).
  Table 2 shows the infection rates by age and gender. Age 
group 23 -27 years had the highest infection rates of 13.05%, 
followed by 18- 22 (11.90 %), then the 28-32 (6.53%). Least 
infection was observed in the 43-47 and 48-52 age groups, 
both with 0.60% prevalence.
4. Discussion
  The high rates of infection observed in the results of this 
study agree with observations of Williams[18] that hepatitis B 
is endemic in parts of China and Africa. The high virulence 
of HBV is captured by Adoga et al[6] who state that HBV 
remains more infectious than HIV. Possibly some of those 
infected could even be chronic carriers[19], who may not 
even be aware of their status.
  Results of this study suggest higher prevalence of infection 
in males than in females. Adoga et al[6] and koulentaki et 
al[14] in separate studies also reported higher prevalence of 
HBV infection in males than in females. No plausible reason 
could be found for this disparity. However this seems to be a 
global trend.
  The high prevalence of co-infection within the more 
youthful age groups is again also consistent with the findings 
of Adoga et al[6] and Koulentaki et al[20]. One possible 
reason is that these age groups could engage in higher risk 
behaviour for contracting HBV, such as sexual activity, drugs 
abuse, tattooing or body piercing, lately an increasing trend 
in Nigeria.
  The high rates of infection with Plasmodia observed could 
be attributed to the fact that malaria is already a looming 
endemic problem in Nigeria, including Benue State. The 
period of the survey July to October, coincided with the 
peak of the rainy season when mosquitoes are breeding 
due to the rains. Moreover Makurdi and its environs is a 
relatively water logged and poorly drained area, gutters and 
other drainages are also routinely clogged with wastes as 
a result of an inefficient public waste disposal system. All 
these provide good breeding sites for mosquitoes which help 
to fuel stable and continuous malaria transmission, even 
beyond the peak rainy season months of November and 
December.
  The reasons advanced above for the individual prevalence 
of each infection could thus have contributed to the 
observed co infection rates. It is also possible that since both 
infections have periods of high activity in the liver, they 
may have synergistic effects on each other? Indeed infection 
Table 1
Monthly prevalence of Plasmodium and HBV co-infection by gender 
(n, %).
Month No. examined
MP/HBI
Male Total
July 48(14.24) 20(5.90) 2(0.60) 22(6.53)
August 60(17.80) 21(6.23) 1(0.30) 22(6.53)
September 40(11.90) 13(3.90) 2(0.60) 15(4.45)
October 62(18.40) 26(7.72) 0(0.00) 26(7.72)
November 68(20.20) 24(7.12) 0(0.00) 24(7.12)
December 59(17.51) 25(7.42) 3(0.90) 28(8.31)
Total 337(100.00) 129(38.30) 8(2.37) 137(40.65)
MP = Malaria parasite infection, HBI = Hepatitis B virus infection.
Table 2
Plasmodium & hepatitis B infection by age and gender (n, %).
Age (year) No. examined
MP/HBI
Male Female Total
18-22  87(25.82)  38(11.30) 2(0.60)  40(11.90)
23-27  97(28.80) 43(12.8) 1(0.30)  44(13.05)
28-32  96(28.50) 22(6.53) 0(0.00) 22(6.53)
33-37 28(8.31) 14(4.15) 2(0.60) 16(4.75)
38-42 24(7.12) 10(7.97) 1(0.30) 11(3.26)
43-47  4(1.19)  0(0.00) 2(0.60)  2(0.60)
48-52  4(1.19)  2(0.60) 0(0.00)  2(0.60)
Total  337(100.00) 129(38.30) 8(2.37) 137(40.65)
MP = Malaria parasite infection, HBI = Hepatitis B virus infection.
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with one or the other pathogen could have led to a weakened 
immunity, thus creating the opportunity for infection with 
the other, as has been found for HIV/Malaria[21].
  Education and re-education of the public remains one of 
the potent tools available for combating the twin diseases of 
malaria and hepatitis B.
  Government owes it as a duty to the citizens to provide 
proper facilities to effectively screen blood and other body 
fluids before they are transfused, as non or inadequate 
screening of blood could lead to infection of persons with 
malarial, HBV or other deadly pathogens.
  The provision and availability of vaccines against HBV is 
currently limited to infants and, mothers and children as a 
national policy. Government vaccination programme should 
be expanded to cover every citizen. Moreover strategies 
should be evolved that every eligible child is covered by the 
programme.
  More aggressive strategies should be adopted in the fight 
against malaria such as extensive environmental insecticide 
spraying, de-clogging of water ways and drainages as well 
as widespread and effective distribution of Insecticide 
Treated Nets (ITNs) and other anti-malarials.
  The fight against these and other infections should be 
relentless until like the fight against small pox and more 
recently, polio, it is won.
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